Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Hermle

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
Journal of Neural Transmission (Vienna, Austria : 1996)|September 22, 2007
Response inhibition in borderline personality disorder: event-related potentials in a Go/Nogo taskM Ruchsow, G Groen, M Kiefer, et al.
Psychopharmacology|April 2, 1999
Psychopathological, neuroendocrine and autonomic effects of 3,4-methylenedioxyethylamphetamine (MDE), psilocybin and d-methamphetamine in healthy volunteers. Results of an experimental double-blind placebo-controlled studyE Gouzoulis-Mayfrank, B Thelen, E Habermeyer, et al.
Fortschritte Der Neurologie-Psychiatrie|December 8, 2004
[AWMF-guideline: cocaine-, amphetamine-, ecstasy- and hallucinogen-related disorders]R Thomasius, E Gouzoulis-Mayfrank, C Karus, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
Journal of Neural Transmission (Vienna, Austria : 1996)|September 22, 2007
Response inhibition in borderline personality disorder: event-related potentials in a Go/Nogo taskM Ruchsow, G Groen, M Kiefer, et al.
Psychopharmacology|April 2, 1999
Psychopathological, neuroendocrine and autonomic effects of 3,4-methylenedioxyethylamphetamine (MDE), psilocybin and d-methamphetamine in healthy volunteers. Results of an experimental double-blind placebo-controlled studyE Gouzoulis-Mayfrank, B Thelen, E Habermeyer, et al.
Fortschritte Der Neurologie-Psychiatrie|December 8, 2004
[AWMF-guideline: cocaine-, amphetamine-, ecstasy- and hallucinogen-related disorders]R Thomasius, E Gouzoulis-Mayfrank, C Karus, et al.
Pageof 6